176 related articles for article (PubMed ID: 26036357)
1. Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target.
Santoni M; Andrikou K; Sotte V; Bittoni A; Lanese A; Pellei C; Piva F; Conti A; Nabissi M; Santoni G; Cascinu S
Cancer Treat Rev; 2015 Jul; 41(7):569-76. PubMed ID: 26036357
[TBL] [Abstract][Full Text] [Related]
2. Feline pancreatic islet-like clusters and insulin producing cells express functional Toll-like receptors (TLRs).
Franchini M; Zini E; Osto M; Jablonski K; Kaufmann K; Lutz TA; Reusch CE; Ackermann M
Vet Immunol Immunopathol; 2010 Nov; 138(1-2):70-8. PubMed ID: 20674989
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
[TBL] [Abstract][Full Text] [Related]
4. Primer: Toll-like receptor signaling pathways--what do rheumatologists need to know?
O'Neill LA
Nat Clin Pract Rheumatol; 2008 Jun; 4(6):319-27. PubMed ID: 18446139
[TBL] [Abstract][Full Text] [Related]
5. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
Saitoh S; Miyake K
Immunol Rev; 2009 Jan; 227(1):32-43. PubMed ID: 19120473
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
7. Primers on molecular pathways: lipopolysaccharide signaling - potential role in pancreatitis and pancreatic cancer.
Del Pozo JL
Pancreatology; 2010; 10(2-3):114-8. PubMed ID: 20460943
[TBL] [Abstract][Full Text] [Related]
8. Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management.
Gambuzza M; Licata N; Palella E; Celi D; Foti Cuzzola V; Italiano D; Marino S; Bramanti P
J Neuroimmunol; 2011 Oct; 239(1-2):1-12. PubMed ID: 21889214
[TBL] [Abstract][Full Text] [Related]
9. Intervention on toll-like receptors in pancreatic cancer.
Vaz J; Andersson R
World J Gastroenterol; 2014 May; 20(19):5808-17. PubMed ID: 24914341
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors: emerging concepts in kidney disease.
Anders HJ; Schlöndorff D
Curr Opin Nephrol Hypertens; 2007 May; 16(3):177-83. PubMed ID: 17420659
[TBL] [Abstract][Full Text] [Related]
11. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
12. Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic Diseases.
Narayanankutty A
Curr Drug Targets; 2019; 20(10):1068-1080. PubMed ID: 30806312
[TBL] [Abstract][Full Text] [Related]
13. A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors.
Kiyokawa T; Akashi-Takamura S; Shibata T; Matsumoto F; Nishitani C; Kuroki Y; Seto Y; Miyake K
Int Immunol; 2008 Nov; 20(11):1407-15. PubMed ID: 18780723
[TBL] [Abstract][Full Text] [Related]
14. Controversial role of toll-like receptors in acute pancreatitis.
Vaz J; Akbarshahi H; Andersson R
World J Gastroenterol; 2013 Feb; 19(5):616-30. PubMed ID: 23431068
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
Krieg AM; Vollmer J
Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
[TBL] [Abstract][Full Text] [Related]
16. The Role of Toll Like Receptors (TLRs) in Oral Carcinogenesis.
Pisani LP; Estadella D; Ribeiro DA
Anticancer Res; 2017 Oct; 37(10):5389-5394. PubMed ID: 28982847
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte toll-like receptor expression in end-stage kidney disease.
Gollapudi P; Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
Am J Nephrol; 2010; 31(3):247-54. PubMed ID: 20090311
[TBL] [Abstract][Full Text] [Related]
18. [Signal transduction pathways mediated by Toll-like receptors and their relations with fungal keratitis].
Chen P; Xie LX
Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):80-4. PubMed ID: 22490919
[TBL] [Abstract][Full Text] [Related]
19. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.
Cole JE; Mitra AT; Monaco C
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1619-35. PubMed ID: 21090937
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor expression in normal ovary and ovarian tumors.
Zhou M; McFarland-Mancini MM; Funk HM; Husseinzadeh N; Mounajjed T; Drew AF
Cancer Immunol Immunother; 2009 Sep; 58(9):1375-85. PubMed ID: 19184006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
